Table 1– Determinants of treatment with chemotherapy in patients with mesothelioma
Subjects nProportion# %Chemotherapy %OR (95% CI)
Site
 Pleural44649417ns
 Peritoneal267616
Tumour type
 Not specified202643131
 Sarcomatoid2265150.9 (0.6–1.4)
 Epitheloid219446221.4 (1.1–1.6)
 Mixed2856151.2 (0.8–1.7)
Sex
 Male41158717ns
 Female6161317
Age yrs
 20–5996120291
 60–69162434210.54 (0.4–0.7)
 70–79163035110.22 (0.2–0.3)
 ≥805161130.04 (0.03–0.08)
Time period
 1995–199813772981
 1999–2002154233111.4
 2003–200484018203.1
 2005–200697221368.4
  • ns: not significant. #: of the whole population; : of the patients in each group.